"PrEP's just to secure you like insurance": a qualitative study on HIV pre-exposure prophylaxis (PrEP) adherence and retention among black cisgender women in Mississippi.

Tiara C Willie, Mauda Monger, Amy Nunn, Trace Kershaw, Jamila K Stockman, Kenneth H Mayer, Philip A Chan, Adaora A Adimora, Leandro A Mena, Deja Knight, Karlye A Philllips, Stefan D Baral
Author Information
  1. Tiara C Willie: Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. twillie2@jhu.edu. ORCID
  2. Mauda Monger: MLM Center for Health Education and Equity Consulting Services, Jackson, MS, USA.
  3. Amy Nunn: Department of Psychiatry, Warren Alpert Medical School of Brown University, Providence, RI, USA.
  4. Trace Kershaw: Department of Social and Behavioral Sciences, Yale School of Public Health, 60 College Street, New Haven, CT, USA.
  5. Jamila K Stockman: Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California, San Diego, La Jolla, CA, USA.
  6. Kenneth H Mayer: Harvard Medical School and Harvard T H Chan School of Public Health, Harvard University, Boston, MA, USA.
  7. Philip A Chan: Department of Psychiatry, Warren Alpert Medical School of Brown University, Providence, RI, USA.
  8. Adaora A Adimora: Department of Medicine, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, USA.
  9. Leandro A Mena: Department of Medicine, University of Mississippi Medical Center, Jackson, USA.
  10. Deja Knight: Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  11. Karlye A Philllips: Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  12. Stefan D Baral: Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD, USA.

Abstract

BACKGROUND: Pre-exposure prophylaxis (PrEP) has the potential to reduce transmission of HIV among Black cisgender women in the Southern United States (U.S.); however, national data suggests that PrEP initiation is lowest in the South and among Black women compared to other U.S. regions and white women. This study applied intersectionality and PrEP multilevel resilience frameworks to assess how socio-structural and clinical contexts shaped PrEP persistence among Black cisgender women in Mississippi.
METHODS: Semi-structured interviews were conducted with eight Black cisgender women in Jackson, Mississippi. This sample was purposively recruited to include PrEP-initiated Black cisgender women.
RESULTS: Six themes identified that shaped PrEP care among Black cisgender women: (1) internal assets, (2) sole responsibility to HIV prevention, (3) added protection in HIV serodifferent relationships, (4) financial issues, (5) trust and distrust in the medical system, and (6) side effects. Black cisgender women reported that PrEP persistence increased control over their sexual health, reduced anxiety about HIV, and promoted self-care. Black cisgender women also indicated that medication assistance programs increased PrEP affordability resulting in continued persistence.
CONCLUSIONS: In addition to preventing HIV, PrEP may yield secondary positive impacts on the health and relationships of Black cisgender women. However, very few Black cisgender women in the South are using PrEP given intersectional barriers and thus necessitates adaptive strategies to support PrEP initiation and persistence. Efforts aimed at increasing the coverage of PrEP among Black cisgender women should consider implementation strategies responsive to lived realities of Black women.

Keywords

References

  1. J Acquir Immune Defic Syndr. 2017 Nov 1;76(3):259-265 [PMID: 28777265]
  2. Qual Health Res. 2010 May;20(5):668-83 [PMID: 20154298]
  3. J Acquir Immune Defic Syndr. 2020 Aug 15;84(5):497-507 [PMID: 32692108]
  4. J Couns Psychol. 2015 Apr;62(2):289-302 [PMID: 25867696]
  5. BMC Public Health. 2020 Jul 28;20(1):1172 [PMID: 32723313]
  6. Health Educ Behav. 2000 Oct;27(5):539-65 [PMID: 11009126]
  7. Nurse Res. 2013 Mar;20(4):12-7 [PMID: 23520707]
  8. Lancet HIV. 2019 Nov;6(11):e800-e806 [PMID: 31570273]
  9. AIDS Patient Care STDS. 2014 Dec;28(12):635-42 [PMID: 25295393]
  10. Am Behav Sci. 2013 Aug 1;57(8): [PMID: 24347666]
  11. AIDS Patient Care STDS. 2018 Dec;32(12):490-494 [PMID: 30036080]
  12. Sex Roles. 2019 May;80(9-10):517-526 [PMID: 31086431]
  13. AIDS Behav. 2019 Jul;23(7):1737-1748 [PMID: 30264207]
  14. Am J Public Health. 2020 Jan;110(1):61-64 [PMID: 31725314]
  15. J Acquir Immune Defic Syndr. 2018 Sep 1;79(1):46-53 [PMID: 29847480]
  16. J AIDS Clin Res. 2017 Sep;8(9): [PMID: 29201531]
  17. J Acquir Immune Defic Syndr. 2021 May 1;87(1):e150-e158 [PMID: 33492024]
  18. JAMA. 2019 Mar 5;321(9):844-845 [PMID: 30730529]
  19. Med Care Res Rev. 2000;57 Suppl 1:146-61 [PMID: 11092161]
  20. Ann Epidemiol. 2018 Dec;28(12):841-849 [PMID: 29983236]
  21. AIDS Behav. 2021 Feb;25(2):582-591 [PMID: 32886220]
  22. AIDS Patient Care STDS. 2015 Feb;29(2):102-10 [PMID: 25513954]
  23. J Couns Psychol. 2017 Oct;64(5):475-486 [PMID: 29048194]
  24. J Racial Ethn Health Disparities. 2020 Oct;7(5):913-927 [PMID: 32078743]
  25. AIDS Behav. 2014 Feb;18(2):226-40 [PMID: 24366572]
  26. Womens Health Issues. 2019 Jan - Feb;29(1):3-7 [PMID: 30292440]
  27. AIDS Behav. 2020 Dec;24(12):3456-3461 [PMID: 32405726]
  28. J Pers Soc Psychol. 1997 Jun;72(6):1460-76 [PMID: 9177025]
  29. Adm Policy Ment Health. 2015 Sep;42(5):533-44 [PMID: 24193818]
  30. J Assoc Nurses AIDS Care. 2019 May-Jun;30(3):321-329 [PMID: 30958408]
  31. Soc Sci Med. 2020 Aug;258:113138 [PMID: 32574889]
  32. Am J Public Health. 2012 Jul;102(7):1267-73 [PMID: 22594719]
  33. AIDS Behav. 2020 Sep;24(9):2509-2519 [PMID: 32048078]
  34. AIDS. 2020 Nov 1;34(13):1951-1957 [PMID: 33009011]
  35. JMIR Public Health Surveill. 2018 Apr 03;4(2):e35 [PMID: 29615383]
  36. J Womens Health (Larchmt). 2012 Mar;21(3):249-54 [PMID: 22196231]
  37. Sex Res Social Policy. 2022 Mar;19(1):180-193 [PMID: 35401855]
  38. Glob Public Health. 2022 Aug;17(8):1451-1466 [PMID: 34061710]
  39. Promot Educ. 2007;Suppl 2:17-22 [PMID: 17685075]
  40. AIDS. 2019 Jun 1;33 Suppl 1:S45-S52 [PMID: 31397722]

Grants

  1. T32 HD064428/NICHD NIH HHS
  2. L32 MD016555/NIMHD NIH HHS
  3. T32 HD094687/NICHD NIH HHS
  4. R25DA035692/NIDA NIH HHS
  5. R61 HD104570/NICHD NIH HHS
  6. R25 DA035692/NIDA NIH HHS
  7. P30 AI036214/NIAID NIH HHS
  8. P30 AI064518/NIAID NIH HHS
  9. K01 MD015005/NIMHD NIH HHS
  10. P30 AI094189/NIAID NIH HHS
  11. R25 MH083620/NIMH NIH HHS
  12. R25MH083620/NIMH NIH HHS
  13. UL1 TR001863/NCATS NIH HHS

MeSH Term

Anti-HIV Agents
Female
HIV Infections
Humans
Insurance
Mississippi
Pre-Exposure Prophylaxis
United States

Chemicals

Anti-HIV Agents

Word Cloud

Created with Highcharts 10.0.0womenBlackPrEPcisgenderHIVamongpersistenceprophylaxisMississippiPre-exposureUSinitiationSouthstudyshapedrelationshipsincreasedhealthstrategiesBACKGROUND:potentialreducetransmissionSouthernUnitedStateshowevernationaldatasuggestslowestcomparedregionswhiteappliedintersectionalitymultilevelresilienceframeworksassesssocio-structuralclinicalcontextsMETHODS:Semi-structuredinterviewsconductedeightJacksonsamplepurposivelyrecruitedincludePrEP-initiatedRESULTS:Sixthemesidentifiedcarewomen:1internalassets2soleresponsibilityprevention3addedprotectionserodifferent4financialissues5trustdistrustmedicalsystem6sideeffectsreportedcontrolsexualreducedanxietypromotedself-carealsoindicatedmedicationassistanceprogramsaffordabilityresultingcontinuedCONCLUSIONS:additionpreventingmayyieldsecondarypositiveimpactsHoweverusinggivenintersectionalbarriersthusnecessitatesadaptivesupportEffortsaimedincreasingcoverageconsiderimplementationresponsivelivedrealities"PrEP'sjustsecurelikeinsurance":qualitativepre-exposureadherenceretentionblackCisgender

Similar Articles

Cited By